# Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035)

> **NCT00106704** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 441 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Comparator: Sitagliptin
- **DRUG:** Comparator: Placebo
- **DRUG:** Comparator: Pioglitazone

## Key facts

- **NCT ID:** NCT00106704
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2006-06
- **Final completion:** 2007-01
- **Target enrollment:** 441 (ACTUAL)
- **Last updated:** 2015-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00106704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00106704, "Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035)". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00106704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*